Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-042316
Filing Date
2020-07-13
Accepted
2020-07-13 19:00:17
Documents
1
Period of Report
2020-07-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3879
  Complete submission text file 0001209191-20-042316.txt   5235
Mailing Address 3595 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address
MACKEY CATHERINE J (Reporting) CIK: 0001645330 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39376 | Film No.: 201026048

Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Issuer) CIK: 0001661460 (see all company filings)

EIN.: 472846548 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)